OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
March 02, 2021
The UK government is taking advantage of the new regulatory flexibility, afforded by Brexit, to boost the country’s competitiveness in pharma.
February 02, 2021
The EC intends to get tougher on issues such as reliability of drug supplies, particularly essential medicines.
January 02, 2021
The recently published European pharmaceutical strategy is being seen as an opportunity to strengthen medicines regulation in the region.
December 02, 2020
The success of virtual GMP inspections performed during the pandemic may lead to more flexible opportunities in the future.
November 02, 2020
The agency is balancing a variety of important issues including the review of COVID-19 vaccines.
October 02, 2020
Regulatory bodies are adapting to new ways of working to cope with the impact of COVID-19.
September 02, 2020
The 2020–2025 EMRN strategy will be regularly reviewed over the coming five years to accommodate science and technology advances.
August 02, 2020
EU regulators are requesting more effective action be taken to tackle serious impurities in APIs and finished products.
July 02, 2020
EMA is facing a dilemma in trying to restore activities back to normal after relocating and the COVID-19 pandemic.
June 02, 2020
The EU’s pharmaceutical strategy has the potential to shake up the policies and regulations of the region’s medicines sector.